An Embryonic and Induced Pluripotent Stem Cell Model for Ovarian Granulosa Cell Development and Steroidogenesis

Abstract

Embryoid bodies (EBs) can serve as a system for evaluating pluripotency, cellular differentiation, and tissue morphogenesis. In this study, we use EBs derived from mouse embryonic stem cells (mESCs) and human amniocyte–derived induced pluripotent stem cells (hAdiPSCs) as a model for ovarian granulosa cell (GC) development and steroidogenic cell commitment. We demonstrated that spontaneously differentiated murine EBs (mEBs) and human EBs (hEBs) displayed ovarian GC markers, such as aromatase (CYP19A1), FOXL2, AMHR2, FSHR, and GJA1. Comparative microarray analysis identified both shared and unique gene expression between mEBs and the maturing mouse ovary. Gene sets related to gonadogenesis, lipid metabolism, and ovarian development were significantly overrepresented in EBs. Of the 29 genes, 15 that were differentially regulated in steroidogenic mEBs displayed temporal expression changes between embryonic, postnatal, and mature ovarian tissues by polymerase chain reaction. Importantly, both mEBs and hEBs were capable of gonadotropin-responsive estradiol (E2) synthesis in vitro (217-759 pg/mL). Live fluorescence-activated cell sorting–sorted AMHR2⁺ granulosa-like cells from mEBs continued to produce E2 after purification (15.3 pg/mL) and secreted significantly more E2 than AMHR2⁻ cells (8.6 pg/mL, P < .05). We conclude that spontaneously differentiated EBs of both mESC and hAdiPSC origin can serve as a biologically relevant model for ovarian GC differentiation and steroidogenic cell commitment. These cells should be further investigated for therapeutic uses, such as stem cell–based hormone replacement therapy and in vitro maturation of oocytes.

Keywords

embryonic stem cells native hormones ovarian tissue regeneration steroidogenesis iPSC

Get full access to this article

View all access options for this article.

References

Bastings

Beerendonk

Westphal

. Autotransplantation of cryopreserved ovarian tissue in cancer survivors and the risk of reintroducing malignancy: a systematic review. Hum Reprod Update. 2019;19(5):483–506.

Shaw

Bowles

Koopman

Wood

Trounson

. Fresh and cryopreserved ovarian tissue samples from donors with lymphoma transmit the cancer to graft recipients. Hum Reprod. 1996;11(8):1668–73.

van der Stege

Groen

van Zadelhoff

. Decreased androgen concentrations and diminished general and sexual well-being in women with premature ovarian failure. Menopause. 2008;15(1):23–31.

Madalinska

van Beurden

Bleiker

. The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy. J Clin Oncol. 2006;24(22):3576–3582.

Ahles

Saykin

. Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer. 2007;7(3):192–201.

Henderson

. Cognitive changes after menopause: influence of estrogen. Clin Obstet Gynecol. 2008;51(3):618–626.

Anasti

Kalantaridou

Kimzey

Defensor

Nelson

. Bone loss in young women with karyotypically normal spontaneous premature ovarian failure. Obstet Gynecol. 1998;91(1):12–15.

Shapiro

Manola

Leboff

. Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer. J Clin Oncol. 2001;19(14):3306–3311.

Kalantaridou

Naka

Papanikolaou

. Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy. J Clin Endocrinol Metab. 2004;89(8):3907–3913.

10.

Beral

Banks

Reeves

. Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet. 2002;360(9337):942–944.

11.

Daly

Vessey

Hawkins

Carson

Gough

Marsh

. Risk of venous thromboembolism in users of hormone replacement therapy. Lancet. 1996;348(9033):977–980.

12.

Ross

Paganini-Hill

Wan

Pike

. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst. 2000;92(4):328–332.

13.

Schairer

Lubin

Troisi

Sturgeon

Brinton

Hoover

. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA. 2000;283(4):485–491.

14.

Grady

Gebretsadik

Kerlikowske

Ernster

Petitti

. Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol. 1995;85(2):304–313.

15.

Lacey

Jr Mink

Lubin

. Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA. 2002;288(3):334–341.

16.

Hubner

Fuhrmann

Christenson

. Derivation of oocytes from mouse embryonic stem cells. Science. 2003;300(5623):1251–1256.

17.

Novak

Lightfoot

Wang

Eriksson

Mahdy

Hoog

. Mouse embryonic stem cells form follicle-like ovarian structures but do not progress through meiosis. Stem Cells. 2006;24(8):1931–1936.

18.

Chen

Kuo

Chien

. Derivation, characterization and differentiation of human embryonic stem cells: comparing serum-containing versus serum-free media and evidence of germ cell differentiation. Hum Reprod. 2007;22(2):567–577.

19.

Psathaki

Hubner

Sabour

. Ultrastructural characterization of mouse embryonic stem cell-derived oocytes and granulosa cells. Stem Cells Dev. 2011;20(12):2205–2215.

20.

Hayashi

Ogushi

Kurimoto

Shimamoto

Ohta

Saitou

. Offspring from oocytes derived from in vitro primordial germ cell-like cells in mice. Science. 2012;338(6109):971–975.

21.

White

Woods

Takai

Ishihara

Seki

Tilly

. Oocyte formation by mitotically active germ cells purified from ovaries of reproductive-age women. Nat Med. 2012;18(3):413–421.

22.

Zhang

. Differentiation of rat iPS cells and ES cells into granulosa cell-like cells in vitro. Acta Biochim Biophys Sin (Shanghai). 2013;45(4):289–295.

23.

Lan

Chen

Jan

Chen

. Differentiation of human embryonic stem cells into functional ovarian granulosa-like cells. J Clin Endocrinol Metab. 2013;98(9):3713–3723.

24.

Woods

White

Niikura

Kiatpongsan

Lee

Tilly

. Embryonic stem cell-derived granulosa cells participate in ovarian follicle formation in vitro and in vivo. Reprod Sci 2013;20(5):524–535.

25.

Gerami-Naini

Dovzhenko

Durning

Wegner

Thomson

Golos

. Trophoblast differentiation in embryoid bodies derived from human embryonic stem cells. Endocrinology. 2004;145(4):1517–1524.

26.

Guven

Lindsey

Poudel

. Functional maintenance of differentiated embryoid bodies in microfluidic systems: a platform for personalized medicine. Stem Cells Transl Med. 2015;4(3):261–268.

27.

Anchan

Gerami-Naini

Lindsey

. Efficient differentiation of steroidogenic and germ-like cells from epigenetically-related iPSCs derived from ovarian granulosa cells. PLoS One. 2015;10(3):e0119275.

28.

Anchan

Quaas

Gerami-Naini

. Amniocytes can serve a dual function as a source of iPS cells and feeder layers. Hum Mol Genet. 2011;20(5):962–974.

29.

Kibbe

Lin

. lumi: a pipeline for processing Illumina microarray. Bioinformatics. 2008;24(13):1547–1548.

30.

Smyth

. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004;3:Article3.

31.

Sassoon

Rosenthal

. Detection of messenger RNA by in situ hybridization. Methods Enzymol. 1993;225:384–404.

32.

Narod

. Hormone replacement therapy and the risk of breast cancer. Nat Rev Clin Oncol. 2011;8(11):669–676.

33.

Beral

Reeves

Bull

Green

Million Women Study

. Breast cancer risk in relation to the interval between menopause and starting hormone therapy. J Natl Cancer Inst. 2011;103(4):296–305.

34.

Hovatta

. Methods for cryopreservation of human ovarian tissue. Reprod Biomed Online. 2005;10(6):729–734.

35.

Shaw

Trounson

. Oncological implications in the replacement of ovarian tissue. Hum Reprod. 1997;12(3):403–405.

36.

Uda

Ottolenghi

Crisponi

. Foxl2 disruption causes mouse ovarian failure by pervasive blockage of follicle development. Hum Mol Genet. 2004;13(11):1171–1181.

37.

Ottolenghi

Omari

Garcia-Ortiz

. Foxl2 is required for commitment to ovary differentiation. Hum Mol Genet. 2005;14(14):2053–2062.

38.

Yoon

Kim

Chung

. Gene expression profiling of early follicular development in primordial, primary, and secondary follicles. Fertil Steril. 2006;85(1):193–203.

39.

Dharma

Modi

Nandedkar

. Gene expression profiling during early folliculogenesis in the mouse ovary. Fertil Steril. 2009;91(suppl 5):2025–2036.

40.

Hasegawa

Kumamoto

Mochida

Komori

Koyama

. Gene expression profile during ovarian folliculogenesis. J Reprod Immunol. 2009;83(1-2):40–44.

41.

Irie

Weinberger

Tang

. SOX17 is a critical specifier of human primordial germ cell fate. Cell. 2015;160(1-2):253–268.

42.

Jadhav

Jameson

. Steroidogenic factor-1 (SF-1)-driven differentiation of murine embryonic stem (ES) cells into a gonadal lineage. Endocrinology. 2011;152(7):2870–2882.

43.

Choate

Resko

. Paradoxical effect of an aromatase inhibitor, CGS 20267, on aromatase activity in guinea pig brain. J Steroid Biochem Mol Biol. 1996;58(4):411–415.

44.

Darabi

Gehlbach

Bachoo

. Functional skeletal muscle regeneration from differentiating embryonic stem cells. Nat Med. 2008;14(2):134–143.

45.

Naftolin

Ryan

Petro

. Aromatization of androstenedione by the anterior hypothalamus of adult male and female rats. Endocrinology. 1972;90(1):295–298.

46.

Sasano

Uzuki

Sawai

. Aromatase in human bone tissue. J Bone Miner Res. 1997;12(9):1416–1423.

47.

Meseguer

Puche

Cabero

. Sex steroid biosynthesis in white adipose tissue. Horm Metab Res. 2002;34(11-12):731–736.

48.

Belanger

Luu-The

Dupont

Tchernof

. Adipose tissue intracrinology: potential importance of local androgen/estrogen metabolism in the regulation of adiposity. Horm Metab Res. 2002;34(11-12):737–745.

49.

Niikura

Tilly

. Aged mouse ovaries possess rare premeiotic germ cells that can generate oocytes following transplantation into a young host environment. Aging (Albany NY). 2009;1(12):971–978.

50.

Aflatoonian

Ruban

Jones

Aflatoonian

Fazeli

Moore

. In vitro post-meiotic germ cell development from human embryonic stem cells. Hum Reprod. 2009;24(12):3150–3159.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.01 MB

0.10 MB

0.04 MB